Finnish Pharma Co. Faron Launches €40M Rights Offer
By Tom Fish ( March 10, 2026, 12:51 PM GMT) -- Faron Pharmaceuticals said Tuesday it has launched a program to raise approximately €40 million ($46.5 million) to support clinical trials for its main cancer drug candidate and finance its operating costs into late 2027....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.